Novo Nordisk
NVO
#15
Rank
NZ$965.06 B
Marketcap
$217.73
Share price
2.00%
Change (1 day)
38.30%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$59.76 B

According to Novo Nordisk's latest financial reports the company's total liabilities are NZ$59.76 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$48.69 B36.07%
2022-12-31NZ$35.78 B30.06%
2021-12-31NZ$27.51 B46.71%
2020-12-31NZ$18.75 B24.05%
2019-12-31NZ$15.11 B12.37%
2018-12-31NZ$13.45 B12.81%
2017-12-31NZ$11.92 B11.63%
2016-12-31NZ$10.68 B11.18%
2015-12-31NZ$9.60 B25.53%
2014-12-31NZ$7.65 B22.29%
2013-12-31NZ$6.25 B15.6%
2012-12-31NZ$5.41 B-10.97%
2011-12-31NZ$6.08 B7.17%
2010-12-31NZ$5.67 B11.76%
2009-12-31NZ$5.07 B-11.7%
2008-12-31NZ$5.75 B45.82%
2007-12-31NZ$3.94 B7.57%
2006-12-31NZ$3.66 B10.65%
2005-12-31NZ$3.31 B17.98%
2004-12-31NZ$2.80 B17.4%
2003-12-31NZ$2.39 B-1.47%
2002-12-31NZ$2.42 B-22.38%
2001-12-31NZ$3.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$207.24 B 246.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$94.13 B 57.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$125.39 B 109.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$98.34 B 64.55%๐Ÿ‡ซ๐Ÿ‡ท France